Latest Breaking News On - Adaptive biotechnologies corporation - Page 1 : comparemela.com

Adaptive Biotechnologies Co (NASDAQ:ADPT) Receives $6 80 Average Price Target from Analysts

Shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the six brokerages that are presently covering the stock, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average […]

Kyle piskelStacyl taylorAdaptive biotechnologies coAdaptive biotechnologies company profilePinnacle wealth planning services incJpmorgan chase coAdaptive biotechnologies corporationGoldman sachs groupFirst trust direct indexingSecurities exchange commissionManchester capital managementAdaptive biotechnologiesGet free reportMarketbeat ratingsExchange commissionCapital management

Does Adaptive Biotechnologies Corporation (ADPT) Have Strong Growth Potential?

Does Adaptive Biotechnologies Corporation (ADPT) Have Strong Growth Potential?
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

Adaptive biotechnologies corporationAristotle atlantic partnersFocus growthAtlantic focus growth strategyBiotechnologies corporationPopular stocks among hedge

Adaptive Biotechnologies (NASDAQ:ADPT) versus Replimune Group (NASDAQ:REPL) Head to Head Contrast

Adaptive Biotechnologies (NASDAQ:ADPT) versus Replimune Group (NASDAQ:REPL) Head to Head Contrast
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesMicrosoft corporationGenentech incReplimune group incGiven replimune groupAdaptive biotechnologies corporationReplimune groupNews ratings for replimune group dailyGet free reportAdaptive biotechnologiesAdaptive biotechnologieBiotechnologies corporationMinimal residual diseaseReplimune group daily

Comparing Replimune Group (NASDAQ:REPL) and Adaptive Biotechnologies (NASDAQ:ADPT)

Comparing Replimune Group (NASDAQ:REPL) and Adaptive Biotechnologies (NASDAQ:ADPT)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesReplimune group incGenentech incMicrosoft corporationNews ratings for replimune group dailyReplimune groupAdaptive biotechnologies corporationGiven replimune groupGet free reportAdaptive biotechnologiesAdaptive biotechnologieBiotechnologies corporationMinimal residual diseaseReplimune group daily

Adaptive Biotechnologies (NASDAQ:ADPT) Trading Down 3 8%

Adaptive Biotechnologies Co. (NASDAQ:ADPT – Get Free Report)’s share price dropped 3.8% on Thursday . The company traded as low as $3.70 and last traded at $3.75. Approximately 393,202 shares changed hands during trading, a decline of 75% from the average daily volume of 1,598,203 shares. The stock had previously closed at $3.90. Wall Street […]

Stacyl taylorAdaptive biotechnologies coJpmorgan chase coSecurities exchange commissionPinnacle wealth planning services incManchester capital managementFirst trust direct indexingAdaptive biotechnologies corporationGoldman sachs groupAdaptive biotechnologiesGet free reportExchange commissionCapital managementWealth planning servicesBiotechnologies corporationAdaptive biotechnologies daily